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The cis-elements that direct packaging and dimerization of retroviral RNAs overlap, and it has been suggested that dimerization is
required for RNA packaging. This also implies that heterodimerization would be necessary for co-packaging and recombination. Moreover,
co-packaging of distinct RNAs may be reduced if incapable of heterodimerizing. In this study, we have designed a novel two-vector rescue
system in which co-packaging and interstrand transfer are necessary for transduction. Thus, the rescue titer is a measure of the ability of a
given vector combination to co-package and subsequently generate a provirus. In the current MLV-based set-up, we explored Akv- and MLV-
like-endogenous virus (MLEV)-derived vectors with modulated dimerization signals. Results show that rescue is influenced by competition
at the level of RNA packaging, as well as complementarity between dimerization elements. Altogether, the results support the hypothesis that
complementarity between dimerization elements may favor co-packaging of distinct retroviral RNAs.
D 2004 Elsevier Inc. All rights reserved.
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The retroviral particle encloses a dimeric RNA genome
consisting of two plus-stranded RNAs, making retroviruses
the only diploid viruses. Packaging of the viral genome is
controlled by an RNA region in the 5Vend of the genome.
Within this RNA domain of MLVs, four stem-loop
structures (SL1–SL4) play a role in the packaging and
dimerization of the viral genome. Experiments with in vitro-
transcribed RNA have identified SL1 (Oroudjev et al.,
1999) and SL2 (Girard et al., 1995, 1996) as strong RNA
dimerization signals. Notably, SL1 and SL2 contain
palindromic sequences of, respectively, 10 (Pal I) and 16
(Pal II) nucleotides. In both structures, the center of these0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: fsp@mb.au.dk (F.S. Pedersen).palindromes is exposed in a loop, and such structures are
referred to as kissing-loops due to the proposed mechanism
of initial recognition by loop–loop base pairing. The
downstream SL3 and SL4 also play a role in the dimeriza-
tion process, possibly as kinetic enhancers by forming
unstable loop–loop interactions (De Tapia et al., 1998; Kim
and Tinoco, 2000; Rasmussen et al., 2002).
With the possible exception of epsilonviruses, potential
kissing-loops are invariantly found among retroviruses and
have been experimentally confirmed in, among others,
human immunodeficiency virus type 1 (HIV-1) (Paillart et
al., 1994; Skripkin et al., 1994), HIV-2 (Dirac et al., 2001;
Jossinet et al., 2001), avian sarcoma leukosis virus (ASLV)
(Fosse et al., 1996; Polge et al., 2000), and Harvey sarcoma
virus (Feng et al., 1995; Rasmussen et al., 2002).
Although RNA dimerization elements are strongly
conserved among retroviruses, disruption of the palindrome
of SL2 of Akv–MLV has no or limited effects on
replication, whereas mutation of SL1 reduces replication,
probably due to increased splicing at the adjacent splice04) 440–453
S.V. Rasmussen, F.S. Pedersen / Virology 329 (2004) 440–453 441donor site (Aagaard et al., 2004). Contrary to Akv,
mutations of the kissing-loop of HIV-1 (dimer initiation
site, DIS) have in most cases resulted in a strong defect in
replication (Clever and Parslow, 1997; Laughrea et al.,
1997; Paillart et al., 1996), and interestingly a recent study
has demonstrated cell-type-dependent effects of DIS dele-
tions on HIV-1 replication (Hill et al., 2003); however, the
mechanism underlying this observation is unknown.
A close relation between the RNA dimerization and
RNA packaging processes is further emphasized by their
sharing of not only cis-acting elements but also of a trans-
acting factor, the nucleocapsid protein (NC). NC is thus
responsible for encapsidation and also enhances reaction
kinetics of RNA dimerization and stabilizes RNA dimers
both in vitro (Feng et al., 1996; Muriaux et al., 1996;
Takahashi et al., 2000) and in vivo (Fu and Rein, 1993; Fu
et al., 1994). This has led to the suggestion that RNA
dimerization may be a prerequisite for RNA packaging (Fu
and Rein, 1993), a notion supported by the observation
that genomic RNA isolated from freshly budded virus
particles was found to be dimeric (Fu and Rein, 1993).
Furthermore, MLV virions containing low levels of viral
RNA due to NC mutations still encapsidate RNA as
dimers (Housset et al., 1993; Meric and Goff, 1989). This
also applies for HIV-1 (Gorelick et al., 1993). Equiva-
lently, when the expression of viral RNA is reduced by
actinomycin D treatment of cells, virions are mostly empty
of viral RNA; however, the residual RNA is dimeric
(Levin et al., 1974). In an intriguing study, Pal et al.
(1998) demonstrated that a hammerhead ribozyme tethered
to the viral packaging signal can guide the degradation of a
second RNA only when both RNAs contain the packaging
signal. This process was independent of Gag protein. This
indicates that dimerization takes place before packaging
and that elements within the packaging signal mediate this
effect (Pal et al., 1998), thereby including the dimerization
elements SL1 and SL2.
As a consequence of their diploidy, retroviruses can
undergo recombination when co-packaging two distinct
RNA strands (Hu and Temin, 1990; Stuhlmann and Berg,
1992). Thus, a demand for RNA dimerization before
encapsidation implies that heterodimerization of two distinct
RNAs would precede co-packaging and be required for
recombination. In previous experiments, we have observed
that a PBS-impaired Akv-derived vector is frequently
rescued by recombination with a MLV-like-endogenous
virus (MLEV) (Mikkelsen et al., 1998a, 1996). In vitro
RNA dimerization also shows that Akv and MLEV RNAs
heterodimerize efficiently (Mikkelsen et al., 2004). Thus,
maybe due to this compatibility between RNA dimerization
elements, Akv is often rescued by recombination. Several
other factors may also influence recombination frequency,
including the expression level of the viral RNAs, their
ability to recruit the packaging machinery, their sequence
homology, and the compatibility of the heterodimeric
genome with the different steps of reverse transcription.To further elucidate this correlation between RNA
heterodimerization, co-packaging and recombination, we
wanted to test if modulation of dimerization elements (SL1
and SL2) in MLEV and Akv would affect co-packaging
and subsequent functionality in post-packaging steps of
replication. In contrast to previous assay systems designed
for studies of recombination (Anderson et al., 2000; Hu
and Temin, 1990; Mikkelsen et al., 2004; Stuhlmann and
Berg, 1992), our new transduction system requires a
mandatory interstrand first-strand transfer but not template
switching during minus-strand synthesis. This results in
much higher rescue titers and offers a more quantitative
approach to functional co-packaging than previously
provided by recombination-dependent rescue systems
(Mikkelsen et al., 2004).
By introducing alternative palindromes and nonpalin-
dromic sequences in SL1 and SL2 positions, we find that
rescue is an effect of packaging competition between RNAs,
as well as compatibility between dimerization elements. The
results support that RNA dimerization occurs before pack-
aging and indicate that complementarity between dimeriza-
tion elements favors co-packaging of distinct RNAs.Results
Functional co-packaging assay
To create a functional co-packaging assay, we sought to
set up a system in which transduction of a defective vector
strictly relies on the formation of heterodimers with a rescue
vector. By allowing co-packaging with a rescue vector, a
titer increase reflects functional co-packaging in vivo; we
refer to this improved transfer efficiency as the drescue
titerT. Notably, in such a scenario the rescue titer is a read-
out of the ability of two vectors to first co-package and next
go through reverse transcription and interstrand transfer and
is therefore a measure of the amount of transduction-
competent heterozygous virus particles produced when co-
expressing two distinct vectors.
Two test-vectors were initially constructed; pPBS-
DTGGAkvC-neo and the rescue vector pPBSProAkvC-
pac. The pPBSDTGGCAkv-neo harbors a mutated PBSPro
(PBSDTGG deletion of 3Vnucleotides in 5V end), an Akv
packaging signal (AkvC), and the neomycin resistance gene
(neo). This PBS mutation was introduced to inhibit initiation
of reverse transcription on the encoded RNA. The
pPBSProAkvC-pac rescue vector harbors a functional
PBSPro and the puromycin (pac) resistance gene. When
pPBSDTGGAkvC-neo and pPBSProAkvC-pac are co-
transfected in a packaging cell, RNA from the two vectors
can co-package in one virus particle. In these heterozygous
virions, reverse transcription can initiate only from the intact
PBSPro situated on pPBSProAkvC-pac (Fig. 1B). Subse-
quently, first-strand transfer may take place to either strand. In
case of an interstrand first-strand transfer, the neomycin gene
Fig. 1. Two vector strand transfer rescue system. (A) pac–pac homozygous virus particles are fully functional and transduce puromycin resistance. (B) pac–
neo heterozygous virus particles rely on PBSPro of the pac-containing strand for initiation of reverse transcription. Subsequently, an interstrand first strand
transfer must take place to reverse transcribe the neo-harboring RNA strand. Transduction will result in a neo-containing provirus. However, heterozygous
virions can also transduce with puromycin if the first strand transfer is intrastrand. (C) neo–neo homozygous virus particles cannot go through reverse
transcription as both strands harbor an impaired PBS.
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Because pPBSDTGGAkvC-neo carries only a small deletion
in the 5Vend of the PBS, base pairing is possible during the
second-strand transfer (Pulsinelli and Temin, 1994). When
this takes place, reverse transcription will generate a neo-
containing provirus (Fig. 1B). From these double-transfected
packaging cells also two different homozygous virion
populations are produced (Figs. 1A + C). In Fig. 1A, the
pac–pac homozygote will transduce with high efficiency
whereas in neo–neo homozygotes (Fig. 1C) both strands
harbor the PBSDTGG and will not contribute significantly to
the rescue titer (see below).
A wide operational window for read-out of functional
co-packaging
To validate the rescue system, pPBSDTGGAkvC-neo
and pPBSProAkvC-pac were either single or co-transfected
into Plat-E packaging cells (see Materials and methods). As
expected, pPBSDTGGAkvC-neo showed a very low trans-
duction titer of approximately 1 CFU/ml (N = 2), thereby
confirming the profound impairment of the PBS, whereas
the pPBSProAkvC-pac transduced with a high efficiency of
approximately 1  106 CFU/ml (N = 2). In double-transfected cells, pPBSDTGGAkvC-neo was rescued,
resulting in a neomycin (G418) titer of 8000 F 2000
CFU/ml (N = 3). Compared to the control, this corresponds
to an approximately 10000-fold increase in titer upon co-
expression of the pPBSProAkvC-pac rescue vector. To ease
and standardize the work, all subsequent experiments were
carried out using frozen media from efficient transfections
(see Materials and methods).
To investigate the rescue mechanism (Fig. 1), proviral
DNA was isolated from 16 neomycin-resistant colonies
obtained by G418 selection of cells transduced with virions
from a pPBSDTGGAkvC-neo + pPBSProAkvC-pac co-
transfection. Subsequently, proviral DNA was PCR ampli-
fied and sequenced through the leader and the PBS region.
In 8 of 16 colonies only PBSPro sequence was detected, and
in only 1 of 16 the DTGG was found. In the remaining
seven colonies, proviral sequences contained both
PBSDTGG and PBSPro. This implies that reverse tran-
scription is initiated on the rescue vector. Alternatively,
DNA recombination between rescue vector and PBS-
impaired vector during the transfection procedure could
potentially also donate a functional PBS; however, if this
were the case, sequences of proviral inserts of transduced
cells would not contain both PBSDTGG and PBSPro. In
Fig. 2. Expression analysis of neo-containing vectors. (A) Work flow of
analysis. (B) RNase protection analysis of pooled Neo-resistant cells.
Above each lane the construct is indicated. The h-actin probe, obtained
from Ambion, was used as an internal control and the pac–neo probe is
shown in Fig. 3 and described in Materials and methods.
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containing vector (pPBSDTGGAkvC-neo) and the high
rescue titer obtained upon co-transfection with a PBS-
functional vector provide a wide window to study effects on
functional co-packaging.
Less efficient functional co-packaging of MLEV with Akv
Previous experiments in our laboratory showed that
PBS-impaired Akv vectors in murine cells are rescued
through recombination with an endogenous MLV-like
virus, designated MLEV (Mikkelsen et al., 1998a, 1996).
By in vitro RNA-dimerization studies, we have shown that
MLEV- and Akv-derived leader RNAs effectively hetero-
dimerize and therefore contain compatible dimerization
signals (Mikkelsen et al., 2004). It was of interest,
therefore, to study functional co-packaging between
MLEV and Akv in a more quantitative approach than
what was possible using previously described recombina-
tion-dependent rescue systems (Mikkelsen et al., 2004). To
fit the system requirements, the MLEV vectors were
constructed as Akv-MLEV chimeras, resulting in the
construct pPBSDTGGMLEVC-neo (approximately 1
CFU/ml, N = 2). In this construct, only the 5V UTR/
packaging signal is MLEV sequence, whereas the LTR and
3VUTR are derived from Akv and therefore identical to the
Akv vectors. This assures complementarity between PBS
sequences and R-regions during strand transfer.
The pPBSDTGGMLEVC-neo vector was co-transfected
with the pPBSProAkvC-pac rescue vector giving rise to a
rescue titer of only 1350 F 600 CFU/ml (N = 3). This
corresponds to a more than 4-fold reduction in rescue titer
compared to the rescue of pPBSDTGGAkvC-neo with
pPBSProAkvC-pac (5800 F 2600 CFU/ml, N = 5)
(frozen media).
Subsequently, an RNase protection assay (RPA) was
carried out to verify a consistent ratio of cellular RNA of
both vectors as this would be an important factor for
comparison of results from individual experiments. The
analysis also included RNA from packaging cells co-
transfected with pPBSDTGGAkvC-neo + pPBSProAkvC-
pac (see above). These experiments showed an approx-
imately 70:30 ratio of pac and neo vector RNA and was
consistent in all experiments. The higher level of expres-
sion of the pac-containing vectors is not surprising
because the neo gene is previously reported to have a
negative effect on RNA expression from retroviral vectors
(Byun et al., 1998).
Equally important for comparison of titer data between
different experiments is that all integrated proviruses will be
equally likely to yield Neo-resistant colonies. This may not
be the case if the various 5VUTR sequences of the different
vector constructs affect translation efficiency. To investigate
this, NIH3T3 cells were stably transfected with different
neo-containing constructs. For all constructs, this gave rise
to 150–200 colonies and by RPA analysis of cellular RNAthe expression level relative to the internal h-actin control
varied less than 5% (Fig. 2). This strongly indicates that the
different 5VUTR sequences do not affect the neo translation
level and therefore do not bias the titer measurements.
Competitive packaging of MLEV and Akv vectors
The reduction in rescue titer (functional co-packaging) of
pPBSDTGGMLEVC-neo compared to pPBSDTGGAkvC-
neo can be a result of reduced packaging of the MLEV
vector compared to the Akv-derived vector. To analyze this,
RNA packaging levels were measured. This was done by
collecting virus-containing media from each relevant trans-
fection, and to each sample adding an external control
consisting of virus supernatant from Plat-E cells transfected
with a hygromycin-containing vector (pMSCV-hyg). Total
virion RNA was purified and subjected to RPA using two
probes as shown in Fig. 3. To obtain a quantitative measure
of packaging efficiency, the amounts of pac and neo vectors
were standardized to the intensity of the hyg band (see
Materials and methods).
Fig. 3. Viral packaging analysis by RPA. Two probes were used: (i) neo–
pac probe for recognition of Akv and MLEV RNAs harboring neo or pac
gene, (ii) a separate probe was used for the external hyg control. (For more
details, see Materials and methods.)
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analysis was carried out by a dilution experiment. Virus-
containing media were harvested from cells transfected with
either a pac-(pPBSProAkvC-pac)- or a neo-(pPBSD-
TGGAkvC-neo)-containing vector and mixed in different
ratios as shown in Fig. 4. This dilution experiment showed
that the neo vector is detectable by RPA when constitutingFig. 4. Validation of packaging assay. Different amounts of pac- and neo-containin
RNA in pac RNA background. To the left, the diagram shows the measured andapproximately 1% or more of total viral RNA. Hence, when
measuring values lower than about 2% of total viral RNA,
there may be a significant contribution from background
radioactivity.
In single-transfected cells, especially the pPBSProAkvC-
pac showed high packaging efficiency with arbitrary pack-
aging units of 3.8 F 0.7 (N = 5) standardized to the external
control. For the neo -containing vectors pPBSD-
TGGMLEVC-neo and pPBSDTGGAkvC-neo packaging
was reduced, showing packaging levels of 1.8 F 0.1 (N = 4)
and 2.2 F 0.2 (N = 3), respectively (Fig. 5).
Although all Akv and MLEV vectors were efficiently
packaged in single-transfected cells, co-expression changed
this picture. When pPBSDTGGAkvC-neo and pPBS-
ProAkvC-pac were co-transfected the neo-containing RNA
constituted only 10 F 1.6% (N = 4) of total viral RNA. The
effect was even more pronounced when pPBSD-
TGGMLEVC-neo was co-transfected with pPBSProAkvC-
pac, in which case only approximately 2% (N = 2) of viral
RNA contained the neo gene that corresponds to a 4- to 5-fold
reduction compared the Akv-derived vector.
In summary, the reduction in rescue titer (functional co-
packaging) of the pPBSDTGGMLEVC-neo compared to
pPBSDTGGAkvC-neo can be attributed to a reduced
packaging level of the MLEV-derived vector.
Introduction of SL1- and SL2-modulated vectors
The above results show that RNA co-packaging may be
affected by the relative packaging efficiencies of the PBS-g virions were mixed and probed to determine the detection limit of the neo
the expected intensities of the neo-containing RNA.
Fig. 5. RNA packaging of Akv and MLEV vectors. To the left, the diagram shows total RNA encapsidation from single transfected cells of the constructs used
in rescue experiments. To the right, the diagram shows packaging competition between the two co-transfected constructs. Vector combinations are indicated
under each column.
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a theoretical maximum when both vectors are packaged in a
1:1 ratio. The MLEV vector (the PBS-impaired vector) is
packaged to a low extent in competition with the Akv-
derived vector. Thus, by increasing the packaging ratio of
MLEV relative to Akv, the functional packaging may
increase. This can be done by either increasing the pack-
aging efficiency of the MLEV vector or reducing the
efficiency of the Akv.Fig. 6. Vector constructs harboring modified SL1 and SL2. In the left panel, th
structure of the modified SL1 and SL2. In the right panel, the equivalent SL1- and S
sequence.It has previously been observed that SL1 and SL2 also
have significant effects on packaging efficiency (Mougel
et al., 1996). Thus, to generate packaging-impaired
MLEV and Akv vectors, nonpalindromic sequences were
introduced in SL1 and SL2 of the respective vectors.
For the Akv-derived vectors, this generated the Akv-
nonpal vectors: pPBSProAkvCnonpalI-pac, pPBSProAkv-
CnonpalII-pac, and pPBSProAkvCnonpalI+II-pac (Fig.
6). In MLEV-derived vectors, the nonpalindromic sequen-e Akv-derived pac-containing rescue vectors are shown with the putative
L2-modified MLEV vectors. The bases in bold indicate the alternative loop
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These vectors were validated by single transfections into
Plat-E and all vectors surprisingly showed packaging
efficiency to wild-type level (Table 1). The MLEV vectors
showed a slight reduction in packaging efficiency. However,
for the Akv nonpal vectors, transduction titers were reduced
2- to 3-fold compared to the parental vector, showing that
nonpalindromic sequences in SL1 or SL2 have a negative
effect on steps of replication succeeding packaging. Due to
the low transduction titer of the PBSDTGG-containing
MLEV vectors, the relative effect on titer of different
constructs cannot be determined.
Functional co-packaging and competitive packaging of
vectors with noncomplementary SL1 and SL2 loop domains
In the first set of experiments, the Akv-nonpal vectors
were used as rescue vectors for the PBS-impaired vec-
tors harboring wild-type packaging signals (pPBSD-
TGGMLEVC-neo and pPBSDTGGAkvC-neo). Analysis
of the relative packaging level in virions from double-
transfected cells revealed that introduction of nonpalin-
dromic sequences in SL1 or SL2 increased the relative
packaging level of the neo-containing vector 2- to 4-fold
(Fig. 7). For both MLEV and Akv, the relative increase was
most pronounced when the rescue vector was the double-
modified pPBSProAkvCnonpalI+II-pac. These packaging
data also illustrate how competitive packaging assays may
resolve minor differences in packaging activity, which are
not resolved in a noncompetitive situation in single-trans-
fected packaging cells (Fig. 7).
The increase in packaging is apparently not reflected in
functional co-packaging. The rescue titer of pPBSD-
TGGMLEVC-neo was found to be 800–900 CFU/ml (N =
3), independent of which of the Akv nonpal vectors were
used as the rescue vector (Fig. 6). This rescue titer is
comparable with the rescue of pPBSDTGGMLEVC-neo
with pPBSProAkvC-pac (1350 F 600 CFU/ml, N = 3),Table 1







pPBSProAkvC.pac 3.8 F 0.8
(N = 5)
7.7  105 F 1.5 
105(N = 3)
pPBSProAkvCnonpalI-pac 3.7 / 5.5
(N = 2)
2.2 / 3.4  105
(N = 2)
pPBSProAkvCnonpalII-pac 4.3 F 5.3
(N = 2)
4.2 / 5.4  105
(N = 2)
pPBSProAkvCnonpalI+II-pac 4.4 / 4.6
(N = 2)
3.5 / 3.1  105
(N = 2)even though the neo/pac packaging ratio is significantly
higher when the Akv nonpal vectors are employed.
However, in rescue experiments involving the Akv nonpal
vectors, there is a lack of complementarity between SL1
and SL2 structures of the PBS-impaired vector and the
rescue vector.
The rescue of pPBSDTGGAkvC-neo shows the same
tendency (Fig. 7). Rescue titers are relatively high; however,
although the neo/pac packaging ratio is increased, func-
tional co-packaging is still reduced 25–35% compared to the
reference situation (pPBSDTGGAkvC-neo + pPBS-
ProAkvC-pac).
Next, the equivalent reverse experiments were performed
using the PBS-impaired MLEV matchnonpal constructs
with a pPBSProAkvC-pac as the rescue vector. With
respect to complementarity, this combination of vectors
resembles the above experiments; however, in this experi-
ment, the PBS-impaired MLEV vector harbors a modulated
dimerization or packaging signal. This was confirmed by
competitive packaging analysis showing that the MLEV
(neo band) was too faint for quantitative measurements
(b1% of total virion RNA) when competing with
pPBSProAkvC-pac rescue vector. The packaging results
were also reflected in the rescue titer of the MLEV-
matchnonpal vectors that all showed titers in the 170–350
CFU/ml (N = 3) range (results not shown).
Comparing the above equivalent experiments in which
the relative packaging ratios have been varied, the data show
a connection between the packaging ratio of the two vectors
and functional co-packaging. Moreover, the lack of com-
plementarity seems to have a negative effect on trans-
duction, which may influence several processes.
Complementary nonpalindromic sequences in SL1 and SL2
direct functional co-packaging
To confirm the positive effect on functional co-packaging
of complementarity between SL1 and SL2 sequences, the
MLEV-matchnonpal vectors (Fig. 6) were co-transfected
with the respective complementary Akv-derived nonpal
rescue vectors, and rescue titer and packaging ratios were
measured. The results are summarized in Fig. 7.
In the competitive packaging analysis, pPBSPDTG-
GMLEVCmatchnonpalI-neo and pPBSPmatchnonpalII-
neo were packaged to 2% (N = 3) of total virion RNA
(Fig. 7), which is equal to the reference situation pPBSD-
TGGMLEVC-neo + pPBSProAkvC-pac (Fig. 7). The
pPBSPDTGGMLEVCmatchnonpalI+II-neo supported
packaging to slightly higher extent of 5% (N = 3) of total
virion RNA level (Fig. 7). Thus, not surprisingly,
introduction of nonpalindromic sequences in both Akv
and MLEV showed a very modest effect on the relative
packaging levels compared to the reference situation. In
contrast to the relative packaging levels, the functional co-
packaging was indeed modulated by the introduction of
matchnonpal sequences in the MLEV constructs (Fig. 7).
Fig. 7. Packaging competition and functional co-packaging of SL1- and SL2-modified constructs. (A) The diagram in the left panel (black columns) shows the
relative neo packaging level when competing with the pac containing rescue vector. In the right panel, the diagram (grey boxes) shows the rescue titers.
Between the columns, the different combinations of co-transfected vectors are shown. (B) The values in the bratioQ column show the transduction titer
normalized to the expected amount of heterodimers calculated from the packaging data shown in the left panel of the diagram (see text for further details).
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compared to the rescue of pPBSDTGGMLEVC-neo by the
same Akv-derived nonpal vectors. This occurred although
the relative packaging level of the neo-vector was
decreased 2-fold. Moreover, when compared to the
reference situation (pPBSDTGGMLEVC-neo + pPBS-
ProAkvC-pac), functional co-packaging was increased 3-
to 4-fold. This strongly indicates that matching non-
palindromic sequences can increase the production of
heterozygous virus particles relative to the reference
situation.Discussion
In this study, we established a new two-vector rescue
system based upon PBS impairment. Compared to previ-
ously reported systems, our design provided a wide window
for the study of functional co-packaging. By combining thisassay with a competitive RNA packaging assay, we were
able to draw several conclusions concerning the formation
of functional heterozygous virions containing MLEV- and
Akv-derived vector RNA. MLEV-derived vectors were
found to package less efficiently than Akv-derived vectors,
and the rescue of PBS-impaired vectors was closely related
to the relative packaging efficiency of the PBS-impaired
vector and the rescue vector. Most importantly, by analyzing
pairwise combinations of mutated vectors, we show (i) that
vectors harboring noncomplementary sequences in the
central dimerization elements (SL1 and SL2) are transferred
with reduced efficiency due to post-packaging effects, and
that such dimerization-mutated vectors are also reduced in
competitive packaging, and (ii) that introduction of com-
plementary nonpalindromic sequences in SL1 and SL2 can
direct co-packaging specificity and thus affect the amounts
of heterozygous virions produced from packaging cells.
The rescue system (as outlined in Fig. 1) relies on
initiation of reverse transcription on the rescue vectors
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transduction of a PBS-impaired vector (PBSDTGG). The
rescue, called functional co-packaging, therefore reflects the
amount of heterozygous virus particles produced from
double-transfected packaging cells but is also dependent
on functionality in post-packaging steps of replication such
as reverse transcription. This kind of strand-transfer rescue
mechanism does not require an binternalQ template switch
during first-strand synthesis and results in high rescue titers.
However, it relates to previously used recombination
systems as the need for co-packaging and post-packaging
functionality is identical.
Therefore, studies of elements specifying functional co-
packaging directly relate to studies of elements specifying
recombination. A similar system has been reported by Yin
and Hu (1997) in which co-packaging is also required for
efficient transduction. However, the system by Yin and Hu
(1997) relies on complementarity between R-regions that in
contrast to our designs gives rise to relatively high back-
ground transduction from homozygous virions. In our set-
up, background titer is extremely low (approximately 1
CFU/ml) due to PBS impairment and results in an opera-
tional window of approximately 10000-fold between no
rescue and rescue with the PBSPro-containing vector.
Sequencing of proviral DNA from neo-resistant colonies
confirms the suggested mechanism in Fig. 1, and repair
mechanisms are in accordance with previously observed
repair of PBS mismatches (Mikkelsen et al., 1998b;
Pulsinelli and Temin, 1994).
This system was combined with competitive RNA
packaging assays (Embretson and Temin, 1987), which
have also previously been applied in RNA packaging
studies in HIV-1 (Luban and Goff, 1994) and SNV/MLV
RNA (Certo et al., 1999). However, contrary to our
experiments, these studies did not relate the packaging
efficiencies under competitive and noncompetitive condi-
tions. In our system, the competitive RNA packaging assay
is based upon transient expression of vector RNA in
packaging cells with stable production of viral proteins. If
done under conditions where the viral protein level is
uncoupled from the expression level of the RNA containing
the packaging signal, noncompetitive packaging assays may
not be able to resolve minor differences between RNAs.
Thus, it is likely that in a noncompetitive system the high
RNA level from the transient transfections may saturate the
packaging machinery and drive packaging of otherwise less
efficiently packable RNAs. However, the competition
situation provides an increased selectivity toward the
RNAwith the more efficient packaging signals. We observe
this phenomenon for the Akv nonpal vectors, which at
noncompetitive conditions package to wild-type level but
are reduced in a competitive situation. Thus, the compet-
itive packaging assay may also be used for more accurate
mapping of positions in the packaging signal contributing
in the packaging process which has not been possible in the
noncompetitive assay.Packaging analysis under competitive conditions
revealed that the reduced functional co-packaging of the
PBS-impaired MLEV vector fully correlated with the
reduction in MLEV packaging relative to the Akv vector.
This reduced packaging of MLEV is observed although the
GACG hairpin pair (SL3, SL4) in the packaging signal is
also found in MLEV (Mikkelsen et al., 1998a) in addition to
the SL1 and SL2 elements analyzed in the present work.
However, several minor scattered sequence differences
between Akv and MLEV may act to reduce the affinity of
the MLEV packaging signal for the Mo-MLV-derived viral
proteins of packaging cells. Nevertheless, there are no clues
to which sequences are involved in this apparent difference,
which does agree with the idea that the Gag protein may
recognize a structure rather than a short sequence motif
(D’Souza et al., 2001).
From the results presented here, it cannot be ruled out
that MLEV-Akv heterozygotes or heterodimers are less
functional than Akv-Akv bheterozygotesQ, but form to an
equal or higher extent. However, it seems unlikely that
MLEV should have a higher specificity for heterodimeriza-
tion with the rescue vector than the equivalent Akv vector.
This is also supported by in vitro RNA dimerization
experiments in which Akv homodimers form efficiently at
lower RNA concentrations than are the MLEV-Akv hetero-
dimer (Mikkelsen et al., 2004). Thus, the data agree with a
model in which the relative packaging efficiency of the two
vectors is important for the level of functional co-packaging
as stated above.
Subsequent introduction of heterologous (nonpalin-
dromic) sequences in Pal I and II of the Akv vectors
reduced transduction 2- to 3-fold. Previous experiments
with Mo-MLV-derived vectors have revealed similar but
more pronounced effects of either deletions (Mougel et al.,
1996) or mutations and deletions of palindromic sequences
in SL1 or SL2 (Ly and Parslow, 2002). In our study,
packaging analysis of SL1- and SL2-modified constructs
revealed no effect on packaging in the noncompetitive
assay. This does not agree with previous work with Mo-
MLV, in which deletions of SL1 or SL2 gave rise to small
reductions in packaging (Mougel et al., 1996), which was
also the case for full-length viruses with insertional muta-
genesis of SL1 and SL2 (Fisher and Goff, 1998). However,
in full-length Akv, deletion or mutation of SL2 did not affect
packaging, whereas deletion of SL1 did reduce packaging
but probably due to increased splicing (Aagaard et al.,
2004). The various results may reflect differences between
Mo-MLV and Akv but may also, for vector-based experi-
ments, be due to experimental differences such as transient
(this study) or stable expression (Mougel et al., 1996) of
vector constructs.
As we observe no effect on packaging by introduction of
nonpalindromic sequences and yet the titer is reduced 2- to
3-fold, this effect must be on the post-packaging level. This
agrees with deletions of SL1 and SL2 in Mo-MLV-derived
vectors in which the packaging reduction did not fully
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experiments indicated that this effect was due to reduced
reverse transcription (Mougel et al., 1996). Similarly, in
HIV-1 mutation of the DIS, both reduce packaging (Clever
and Parslow, 1997; Paillart et al., 1996) and reverse
transcription (Paillart et al., 1996). Other experiments using
melting analysis of genomic RNA dimers suggest a possible
role of the dimeric genome in first strand transfer (Berkhout
et al., 1998).
When MLEV or Akv-derived vectors harboring non-
palindromic dimerization elements were analyzed in a
competitive packaging situation with the parental vectors,
their packaging ratio was reduced. The various experiments
changing the packaging ratio of the PBS impaired vector
and the rescue vector are in accordance with a model in
which functional co-packaging is affected in a positive
direction by an increase in the packaging ratio of the PBS-
impaired vectors, but in a negative direction by the lack of
complementarity between dimerization elements in PBS-
impaired vector and the rescue vector (Fig. 7). However, an
increase in the packaging of the PBS-impaired vector will
affect functional co-packaging in a positive direction only as
long as the packaging ratio of the PBS-impaired vector
relative to the rescue vector is less than 1:1. If the packaging
of the PBS-impaired vector is increased further, functional
co-packaging will again be reduced, because the rescue
vector will be out competed.
The lack of complementarity may affect functional co-
packaging in several processes such as (i) packaging
competition, (ii) reduced post-packaging functionality as
demonstrated above, or (iii) a nonrandom formation of
heterozygous virus particles, as vector RNAs harboring
palindromic dimerization signals may preferentially package
as homodimers.
In an effort to separate possible effects of post-
packaging functionality due to the lack of complementarity
and nonrandom dimer formation, MLEV-matchnonpal
vectors were co-transfected with the Akv-nonpal rescue
vectors harboring complementary dimerization elements.
These changes showed a modest effect on the relative
packaging ratios but had a clear impact on functional co-
packaging (Fig. 7). For example, both MLEV wt and
MLEV matchnonpal I package to approximately 2% of
total virion RNA when rescued with Akv wt and Akv
nonpal I, respectively. According to a model in which
RNA co-packaging is random, the population of homo-
zygous and heterozygous virions is described by a Hardy–
Weinberg distribution and in both situations an approxi-
mately 4% (0.04 = 2  0.02  (1  0.02)) of the virions
would be heterozygous. Thus, if the complementary
MLEV matchnonpal and Akv nonpal sequences have a
post-packaging functionality equivalent to the wild-type
sequences, then functional co-packaging would be similar
in the two experiments. Nevertheless, the rescue of MLEV
matchnonpal I is increased 3-fold compared to the wild-
type situation. Similar calculations are shown in the rightcolumn in Fig. 7 that shows the transduction titer
normalized to the expected amount of heterozygous virus
particles formed if packaging process should follow a
Hardy–Weinberg distribution. It is unlikely that these
heterologous sequences should support post-packaging
functionality to a higher extent than the wild-type SL1
and SL2 sequences. Thus, these results are indicative of a
relative increase in the percentage of heterozygous virus
particles, when the two vectors harbor complementary
nonpalindromic sequences. If functionality of the alter-
native dimerization sequences is reduced compared to the
wild-type sequences, the heterodimerization level may be
significantly higher. This may well be the case, as
alternative palindromic sequences in SL1 and SL2 can
reduce transduction efficiency (Ly and Parslow, 2002;
Mikkelsen et al., 2004). Evidently, complementarity
between SL1 and SL2 is not strictly required for co-
packaging as functional co-packaging of vectors harboring
noncompatible SL1 and SL2 elements can be observed,
which is also the case for HIV-1 constructs harboring
noncomplementary DIS structures (St Louis et al., 1998).
Consequently, if dimerization is a prerequisite for pack-
aging, then dimerization must take place through other
regions than SL1 and SL2. This is consistent with previous
results showing that although both SL1 and SL2 are
deleted, retroviral genomes are still dimeric (Ly and
Parslow, 2002). Moreover, Mo-MSV and SNV can co-
package (Yin and Hu, 1997) although SNV and Mo-MSV
do not contain complementary Pal I and -II sequences
(Konings et al., 1992).
Additional dimerization signals could be other palin-
dromic sequences or possibly the downstream GACG stem-
loops that are strongly involved in the packaging step
(Fisher and Goff, 1998; Mougel and Barklis, 1997; Mougel
et al., 1996), and which by loop–loop interactions are
capable of forming unstable dimers (Kim and Tinoco,
2000). As the presence of GACG stem-loops enhances in
vitro dimerization kinetics (De Tapia et al., 1998; Rasmus-
sen et al., 2002), it is possible that these loop–loop
interactions drive the initial dimerization, which is then
stabilized by SL1 and SL2. Moreover, GACG stem-loops
have been demonstrated to drive heterodimerization
between distantly related viruses in vitro (Rasmussen et
al., 2002), and notably SNV and Mo-MSV both contain
GACG motifs.
Thus, the data do not suggest that SL1 and SL2 directly
control the specificity in dimerization and subsequent co-
packaging. The results are more consistent with a model in
which a lack of complementarity reduces packaging of a
potential dimer. Exemplified with experiments of co-
transfected MLEV matchnonpal and Akv nonpal vectors,
the MLEV and Akv homodimers are possibly relatively
poorly packaged due to mismatch in the SL1 and SL2
sequences. This would then favor packaging of the
MLEV-Akv heterodimers in which the dimerization
elements are complementary. In conclusion, the observa-
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enhances co-packaging also adds proof to the hypothesis
that dimerization directed by these elements occurs before
packaging.Materials and methods
Vector construction—introduction of PBSDTGG
The pPBSProAkvC-pac has been described before
(Mikkelsen et al., 2004). This vector contains the Akv–
MLV long terminal repeats, a primer binding site (PBS)
matching proline tRNA, and the puromycin resistance gene
(pac) flanked upstream by the 5Vleader region and down-
stream by 480 bp Akv sequences including the 3Vuntrans-
lated region.
The impaired PBSDTGG was initially introduced into
pPBSProAkv240C-neo. This vector has previously been
described (Mikkelsen et al., 1996). For ease of subsequent
cloning of mutated PBS sequences, restriction sites for SrfI
and NruI were created in pPBSProAkv240C-neo at
positions 952 and 1018, respectively, at which half sites
for SrfI and NruI exist. A DNA fragment containing
restriction sites for SrfI and NruI was obtained by two-step
PCR and overlap extension. pPBSProAkv240C-neo was
used as template for two PCRs (PCR1 and PCR2) with
primers, ON1 plus ON2 and ON3 plus ON4, respectively.
All oligonucleotides used for construction and analysis are
listed in Table 2. The two PCR fragments of 930 and 720 bp
were combined in an overlap extension reaction under
standard PCR conditions but also including 1.25 U of PfuTable 2























ON22 5V-TAGCGGTTGCTGGATCGCAATGAGCTTpolymerase (Stratagene). By insertion of the product
(PCR3) into pPBSProAkv240C-neo, pPBSProAkv240C-
neo SrfI–NruI was generated. A DNA fragment comprising
the PBS in which the TGG sequence had been deleted was
obtained by mixing 100 pmol each of oligonucleotide ON5
and ON6, heating to 95 8C for 5 min, and reannealing by
slow cooling to room temperature. pPBSProAkv240C-neo
Srf1–Nru1 was digested with SrfI and NruI and the 3V
terminal sequence of the digested vector removed by the 3Vto
5Vexonuclease activity of T4 DNA polymerase. The DNA
fragment was inserted into this vector by standard ligation,
resulting in pPBSDTGGAkv240C-neo. This construct, as
all other constructs, was checked by restriction digest and
sequencing.
In the following steps, the PBSDTGG sequence was
introduced into pPBSDTGGAkvC-neo and pPBSD-
TGGMLEVC-neo by two-step PCR in all cases using the
Expanded High Fidelity PCR kit (Roche). The upstream
PCR product (PCR1) contains the Akv-derived LTR regions
and the PBSDTGG, the downstream PCR product (PCR2)
contains the packaging signal of either Akv or MLEV, and
in the overlap PCR product (PCR3) the two fragments are
joined and subsequently cloned into appropriate sites in
pPBSProAkv240C-neo.
For pPBSDTGGMLEVC-neo cloning, pPBSDTGGA-
kv240C-neo was used as a template in a PCR reaction
using the upstream primer ON7 and the downstream
primer ON8. The 3V part of ON7 recognizes a sequence
in the vector upstream the provirus and the 5Vpart contains
a heterologous sequence. The 3Vpart of ON8 recognizes the
PBSDTGG and the 5Vend is MLEV leader sequence. This
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generated using the pPBSDTGGAkv240C-neo as a tem-
plate for a PCR with the primers ON7 and ON9. ON9
recognizes the most upstream part of the Akv leader
sequence. This PCR generates a product of 844 bp
designated PCR1-DA.
To incorporate the MLEV packaging signal, a second
PCR was done using pMLEV leader pac (described
in Mikkelsen et al., 2004) as a template and with
the sense primer ON10 and the pac antisense pri-
mer ON11 to generate PCR2-MP of 547 bp. The Akv
packaging signal was acquired by PCR using the
previously described pPBSProAkvC-neo (Mikkelsen et
al., 2004) as template for PCR with the sense pri-
mer ON12 and the neo antisense primer ON13 (PCR2-
AN of 546 bp). In the overlap extension PCR (PCR3),
the DNA fragments PCR1-DM and PCR2-MP were
joined using the primers ON14, which recognize
unique sequences in the 5Vend of ON7, and ON11. This
1360-bp PCR product was designated PCR3-DMP. For
Akv cloning, the DNA fragments PCR1-DA and PCR2-
AN were joined using ON14 and ON13, thus gene-
rating the 1365-bp PCR3-DAN. Following purifi-
cation, PCR3-DAN and PCR3-DMP were digested
with BamHI and EcoRI and by standard cloning
techniques inserted into EcoRI–BamHI-digested pPBS-
DTGGAkv240C-neo. This generated pPBSDTGGAkvC-
neo and pPBSDTGGMLEVC-neo, respectively.
Vector construction—introduction of nonpalindromic
sequences in SL1 and SL2 in MLEV and Akv vectors
Introducing nonpalindromic sequences in SL1 and SL2
was also done by two-step PCR as above. However, a new
set of degenerated primers was used. For MLEV, ON15
introduces matchnonpal I and in Akv, ON16 introduces
nonpal I. The templates, pMLEVAkv leader-pac, pMLEV-
leaderKLmatchnonpalA-pac (harbors matchnonpal II), and
pPBSProAkvCnonpalII-neo (pPBSMutAkvCKLnonpalA-
neo) are available from previous experiments (Mikkelsen
et al., 2004). These primers and templates were used in
several PCR2s: PCR2a: ON15 + ON11 with pMLEVAkv-
leader-pac as a template (553 bp), PCR2b: ON10 + ON11
with pMLEVleaderKLmatchnonpalA-pac as a template,
PCR2c: ON15 + ON11 with pMLEVleaderKLmatchnon-
palA-pac as a template. For Akv, the following PCR2s were
done: PCR2d: ON16 + ON13 with, pPBSProAkvCnonpalII-
neo as a template (529 bp), PCR2e: ON19 + ON13 with,
pPBSProAkvC-neo as a template, PCR 2f: ON16 + ON13
with pPBSProAkvCnonpalII-neo as a template.
All of the PCR2 products (PCR2a–f) were purified and
used in an overlap extension PCR (PCR3). For MLEV
constructs, PCR products PCR2a–c were mixed with PCR1-
DM and with the use of ON14 and ON11 PCR1-DM was
joined to PCR2a–c, thereby generating PCR3a–c (1357 bp).
For Akv, ON14 and ON13 were used to join PCR1A-Pro tothe PCR2 products PCR2d–f, thereby resulting in the PCR3
products PCR3d–f (1350 bp). All PCR3 products (PCR3a–
f) were purified and EcoRI–BamHI digested. Subsequently,
PCR3a–c were inserted by standard cloning techniques into
EcoRI–BamHI-digested pPBSProAkv240C-neo, thus gen-
erating the clones pPBSDTGG MLEVCmatchnonpalI-neo,
-matchnonpalII-neo, and -matchnonpalI + II-neo, respec-
tively. Similarly, PCR3d–f were inserted into EcoRI–
BamHI-digested pPBSProAkvC-pac, thereby generating
the clones pPBSProAkvCnonpalI-pac, -nonpalII-pac, and
-nonpalI + II-pac.
Cell culturing, transfection, and transduction
NIH3T3 and Plat-E (Morita et al., 2000) cells were
incubated at 37 8C in 90% humidity and 5.7% CO2 using
Dulbecco’s modified Eagle medium with Glutamax-1
(Invitrogen) supplemented with 10% newborn calf serum
(NIH3T3) or 10% fetal calf serum (Invitrogen) (Plat-E), 100
U penicillin per ml, and 100 Ag/ml streptomycin.
Calcium phosphate transfection of packaging cells has
been described previously (Mikkelsen et al., 1996). Briefly,
Plat-E cells were seeded at 7  104 cells/cm2 1 day before
transfection in T80 culture bottles. The standard transfection
mixture contains 10 Ag of each vector plasmid or 10 Ag of
pUC19 along with 1 Ag of pIRES-EGFP (Clontech) as a
transfection control. Sixteen hours post-transfection, the
cells were washed in PBS and 10 ml of fresh medium was
added. The following day viruses were harvested and either
used directly for transduction experiments or frozen in
aliquots for later transduction experiments or packaging
analysis.
Virus-containing media from transfected Plat-E cells
were filtrated through a sterile 0.20-Am pre-filter. One day
before transduction, NIH3T3 cells were seeded at 5  103
cells/cm2 in 6-well dishes. The filtered medium was serially
diluted and in the presence of 6 Ag/ml of polybrene (Sigma)
transferred to NIH3T3 target cells, two wells for each
dilution. Medium containing G418 (0.6 mg/ml) or puromy-
cin (1.5 Ag/ml) was added to NIH3T3 cells 24 h post-
transduction and resistant colonies were counted after 10–11
days of selection.
Well-defined colonies were isolated and grown to
confluency in 6-well dishes. Genomic DNA was prepared
using DNAzol (Molecular Research Center, Inc.). By use of
a neo antisense primer ON17 and a U5 sense primer ON18,
an approximately 1500-bp PCR band was generated. The
purified PCR product was sequence analyzed in both
directions using automated DNA sequencer (Applied Bio-
systems Inc.) with appropriate primers.
Calcium phosphate transfection of NIH3T3 cells for
RNA expression analysis was done as previously described
(Mikkelsen et al., 1996). Medium containing G418 (0.6 mg/
ml) was added to the cells 24 h post-transfection and
resistant colonies were counted and pooled after 12 days of
selection.
S.V. Rasmussen, F.S. Pedersen / Virology 329 (2004) 440–453452Cellular and viral RNA preparation and analysis
Three days post-transfections of Plat-E cells, total
cellular RNA was isolated with TriReagent (Sigma) as
specified by the manufacturer. The stably transfected and
pooled NIH3T3 cells were seeded to 5  103 cells/cm2 and
grown for 2 days in G418-containing media before harvest-
ing of total cellular RNAwith TriReagent (Sigma). All RNA
preparations were quantified with UV absorbance and 5 Ag
was run on a native agarose gel for a control of RNA
integrity. Subsequently, RNase protection assay was per-
formed using the RPA III kit (Ambion). Probes were
produced by in vitro RNA transcription using the T7
Maxiscript kit (Ambion) with [a-32P]UTP 800 Ci/mmol
(Hartman) as the radioactive source.
The pac-neo-probe was generated by a PCR with the
primers ON19 and ON20 on a pPBSProAkvC-pac tem-
plate. The 3Vend of ON20 recognizes a unique sequence in
the downstream part of the pac ORF; furthermore, it has a
25-nt tail of heterologous sequence. The 5Vend of ON19
contains the T7 promoter and the 3V end recognizes a
sequence in the 3VUTR contained in both pac and neo
vectors. In vitro transcription of this PCR product generates
a 338-nt full-length probe. The pac-containing vector RNA
will protect a fragment of 307 nt and neo-containing vector
RNAs protect a 209-nt long fragment. The h-actin probe
was obtained from Ambion RPA III kit and yields a 304-nt
probe that protects a 250-nt fragment of the mouse h-actin
RNA.
Probes were hybridized to target RNA in hybridization
buffer at 42 8C for 20 h. Following digestion with RNase A
and T1, the protected fragments were analyzed with 5%
polyacrylamide-urea gel electrophoresis. Documentation
and quantification of protected fragments were done by
use of Kodak Phosphorimager screens, Biorad Personnel
FX scanner, and Biorad Quantity One software.
For packaging analysis, virus supernatants used also for
the transduction experiments were filtered (pore size 0.2
Am) and frozen in 1-ml aliquots. An external control was
also prepared by transfecting Plat-E cells with pMSCV-hyg
(Clontech). Each sample of 1 ml of virus-containing
medium was then added 0.3 ml of medium from pMSCV-
Hyg-transfected cells and centrifuged in microcentrifuge
tubes (4 8C) for 2 h (18500  g). Supernatant was removed
and 500 Al of TriReagent (Sigma) was added with 10 Ag of
yeast RNA and RNA was isolated as specified by the
manufacture. RNA pellets were resuspended and treated
with Turbo DNase (Ambion) for 20 min at 37 8C.
Following DNase treatment, the probes were added and
the entire sample was NH4Ac/EtOH precipitated. For all
packaging experiments, the 338 nt pac-neo-long probe was
used (see above). In addition to the pac-neo-probe, a hyg-
probe was designed to quantify the external control
(pMSCV-hyg). The hyg-probe was produced by in vitro
transcription of a PCR-generated template. For this, PCR
primers ON21 and ON22 were used on a pMSCV-hygtemplate. ON21 contains the T7 promoter, whereas ON22
contains a heterologous sequence of 22 nt in the 5Vend. By
in vitro transcription, this results in a 181-nt full-length
probe, and following RNase treatment the hyg sequence
protects a fragment of 153 nt. The different lengths of
protected and unprotected fragments allow easy discrim-
ination of pac, neo, and hyg-protected fragments. Hybrid-
ization, RNase treatment, gel electrophoresis, and gel
documentation were done as described above.Acknowledgments
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